CoChat
Sign Up
Cited by 70Diabetes Management and ResearchRetinal Diseases and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: A multinational study

Open access
West, K. M., Ahuja, M. M. S., Bennett, P. H., Grab, B., Grabauskas, V., Mateo-de-Acosta, O., Fuller, J. H., Jarrett, R. J., Keen, H., Kosaka, K., Krolewski, A. S., Miki, E., Schliack, V., Teuscher, A.·1982·Diabetologia
DOI 10.1007/bf00282582
Open this paper in CoChat — free accountOpen PDF

Abstract

In a multinational study, fasting plasma glucose values in 3583 diabetic patients, aged 34-56 years, were related to the characteristics of these subjects and to the presence and severity of microangiopathy as ascertained by standardised methods. The patients were from nine different populations and ranged in number from 193 to 686 per population (London, Warsaw, Berlin (FRG), New Delhi, Tokyo, Havana, Oklahoma Indians, Arizona Pima Indians, and a national sample in Switzerland). In the total group, mean fasting plasma glucose was 8.1 mmol/l for those on diet alone, 9.7 mmol/l for those on oral agents, and 12.7 mmol/l for insulin-treated patients, of whom 25% had values exceeding 16.5 mmol/l. Since many variables were measured in each patient, it was possible to take into account many confounding factors in evaluating the relationship of plasma glucose levels to retinopathy and nephropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00282582

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hyperglycaemia and hyperinsulinemia are involved in the development of long-term complications in NIDDM.

    “Furthermore,hyperglycaemia as well as hyperinsulinemia is involved in the development of long-term complications inherent in this disease [18, 19].”

    From The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients (1997) · cites this paper as [19]

    The Plasma Glucose and Microvascular Disease section reports more retinopathy and proteinuria with higher glycaemia, supporting the hyperglycaemia part. The Discussion describes glucose as a possible risk factor and notes that the study was cross-sectional, so it does not establish a causal role in development. The passages on insulin concern treatment status, not hyperinsulinemia; they do not support that part of the claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Metadata

Authors
West, K. M., Ahuja, M. M. S., Bennett, P. H., Grab, B., Grabauskas, V., Mateo-de-Acosta, O., Fuller, J. H., Jarrett, R. J., Keen, H., Kosaka, K., Krolewski, A. S., Miki, E., Schliack, V., & Teuscher, A.
Affiliations
World Health Organization (CH)
ORCID
Venue
Diabetologia
Publisher
Springer Science and Business Media LLC
Published
1982-06
Volume
22
Issue
6
Pages
412-420
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
DOI
10.1007/bf00282582
OpenAlex
W1968492285
Cited by
68
References
8
Citations by year
2025: 1 · 2024: 1 · 2020: 2 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 2
FWCI
3.75
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Lithuanian University of Health Sciences (submittedVersion)
Funders
  • World Health Organization
  • University of Oklahoma
  • National Institutes of Health
  • University of Oklahoma Health Sciences Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetic microangiopathy, fasting blood glucose, diabetic retinopathy, diabetic nephropathy, diabetes mellitus, insulin therapy, oral antidiabetic drugs, dietary therapy, risk factors, hyperglycemia, cross-national comparison
MeSH terms
Adult, Blood Glucose, Blood Pressure, Diabetes Mellitus, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Insulin, Male, Middle Aged, Proteinuria, Risk

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review